Navigation Links
ERT Files Shelf Registration Statement
Date:11/10/2010

PHILADELPHIA, Nov. 10, 2010 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERES), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, today announced it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (the "SEC").   While the Company does not have the present intention to conduct an offering of securities registered pursuant to the registration statement, the registration statement, when declared effective by the SEC, will permit the Company to offer and sell from time to time in one or more public offerings up to $150 million aggregate dollar amount of its securities, which may consist of any combination of the Company's debt securities, shares of preferred stock (either separately or represented by depositary shares), common stock and warrants, as well as units that include any of these securities, on terms, in each case, established at the time of the offering.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective.  These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification of such securities under the securities laws of any such jurisdiction.  Any offering may be made only by means of the prospectus included in the registration statement and one or more related prospectus supplements that may be used with respect to such offering.

About eResearchTechnology, Inc.

Based in Philadelphia, PA, eResea
'/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
4. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
7. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
8. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
9. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
10. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
11. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... N.J. , March 26, 2015 IGI ... Jersey based specialty generic pharmaceutical company, today ... application (ANDA) to the U.S. Food and Drug Administration ... of ANDA submissions now pending at the FDA to ... CEO of the Company, commented, "On March 2, 2015, ...
(Date:3/26/2015)...  CNBC profiled MJ Freeway , a business software ... "How I Did It," which features companies with unique paths ... released yesterday, illustrates how two tech entrepreneurs from ... the marijuana industry. ... Poinsett and Jessica Billingsley used their experience in ...
(Date:3/26/2015)... 26, 2015 Editor Note: ... bottom . Investor-Edge has initiated coverage on ... Salix Pharmaceuticals Ltd (NASDAQ: SLXP ), Hospira Inc. ... ), and Akorn Inc. (NASDAQ: AKRX ). Free ... http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets declined on Wednesday, March ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It" 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5
... LITTLE FALLS, N.J., Feb. 2, 2011 Projects ... provider of continuing medical education (CME/CE) activities, previously ... game-changing Living Medical eTextbook. Now the iPhone app ... recognized by iMedicalApps ( www.imedicalapps.com ) as one ...
... and PRINCETON, N.J., Feb. 2, 2011 Eli Lilly ... Squibb Company (NYSE: BMY ) announced today ... two global Phase III studies evaluating necitumumab, an investigational ... cell lung cancer (NSCLC). (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) ...
Cached Medicine Technology:Living Medical eTextbook iPhone App from Projects In Knowledge® Named to Top 20 List of Free Medical Apps 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 3Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 4Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 5Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 6Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 7Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 8Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 9Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 10
(Date:3/27/2015)... Airy Jeanine is a rising star. ... video for her debut song “Mama’s Girl”, launched on ... abstract styling effects, the thematic video for the rhythmic ... and assorted outlets. It will be integral in establishing, ... full-scale marketing strategy. The video promotion campaign spearheaded by ...
(Date:3/27/2015)... 27, 2015 “ VXi BlueParott Reveal ... monthly Tech Report, which features the latest and coolest ... expert and special reporter for NewsWatch, conducted the review ... noise-cancelling headset, eliminating 90% of ambient noise. , Today, ... and emails are important to any professional, voice calls ...
(Date:3/27/2015)... March 27, 2015 The ... Quaker-based, philanthropic, grant-making foundation committed to raising its ... healthcare is delivered. , The Scattergood Foundation and ... Behavioral Health Policy and Practice through the Annual ... Program App is designed to guide the ...
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served as ... and has trained over 6500 surgeons through these meetings ... medicine (EBM), that is, the optimization of decision making ... often hear from rhinoplasty surgeons who describe ... not trying to stifle these discussions, we do want ...
(Date:3/26/2015)... The American College of Traditional Chinese Medicine ... of the DAOM Program as well as Marketing Basics for ... be hosted by Dr. Carla Wilson, who will give an ... how to prepare for the spring quarter. The webinar will ... April 1 and April 3. Attendees can log in from ...
Breaking Medicine News(10 mins):Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:ACTCM Announces Upcoming Webinars 2
... seen with DHA, either in terms of prevention or ... Two trials that looked at whether the omega-3 fatty ... produced mixed results. , The studies were done because ... fish consumption to cognitive function," explained Bill Thies, chief ...
... A ... Meeting in Keystone, Colorado, (July 9-12) details the benefits and risks of repairing a torn ... ... More and more children are participating and getting hurt playing sports each year. A new ...
... , , NEW YORK ... Sub-Saharan Africa as president, Barack Obama today gave an historic speech ... address the deadly public health voids in many African countries, the ... mothers, noting "...too many still die from diseases that shouldn,t kill ...
... Mayo Clinic study may help physicians differentially ... study will be presented at the Alzheimer,s Association International ... , In this study, Mayo Clinic researchers developed ... neurodegenerative disorders: Alzheimer,s disease , frontotemporal lobar ...
... ... will join three other North American physicians as a 2009 American Orthopaedic Society ... ... John Bergfeld, MD, Cleveland Clinic Foundation, Director of Operating Room Management, will join three ...
... The Council for American Medical Innovation today applauded President ... head the National Institutes of Health (NIH). , ... ) , , "Dr. Collins is both a ... medical innovation," said Council President Dick Gephardt. "His passion ...
Cached Medicine News:Health News:Omega-3 Fatty Acid Falls Short in Alzheimer's Trials 2Health News:Omega-3 Fatty Acid Falls Short in Alzheimer's Trials 3Health News:Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows 2Health News:Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows 3Health News:Obama: 'Too Many Still Die from Diseases That Shouldn't Kill Them...' 2Health News:Mayo Clinic study using structural MRI may help accurately diagnose dementia patients 2Health News:Renowned, Cleveland Clinic Foundation, Orthopaedic Sports Medicine Surgeon, John Bergfeld, MD, Inducted into Sports Medicine Hall of Fame 2Health News:Council for American Medical Innovation Applauds Appointment of Geneticist Francis Collins to Head National Institutes of Health 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: